{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:39:50Z","timestamp":1787647190205,"version":"build-2736575974"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>\n                    Although diagnosis of high-grade uterine mesenchymal tumors (UMTs) exhibiting classic morphologic features is straightforward, diagnosis is more challenging in tumors in which prototypical features are poorly developed, focal, and\/or coexist with features seen in other neoplasms. Here, we sought to define the repertoire of somatic genetic alterations in diagnostically challenging UMTs with myomelanocytic differentiation, including some reported as perivascular epithelioid cell tumors (PEComas). In 17 samples from 15 women, the tumors were histologically heterogenous. Immunohistochemical expression of at least 1 melanocytic marker (HMB45, Melan-A, or MiTF) was identified in all tumors, and of myogenic markers (desmin or smooth muscle actin) in most tumors. Targeted massively parallel sequencing revealed several genetic alterations, most commonly in\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    (41% mutation, 12% deletion),\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    (29% mutation, 6% deletion),\n                    <jats:italic toggle=\"yes\">RB1<\/jats:italic>\n                    (18% deletion),\n                    <jats:italic toggle=\"yes\">ATRX<\/jats:italic>\n                    (24% mutation),\n                    <jats:italic toggle=\"yes\">MED12<\/jats:italic>\n                    (12% mutation),\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    (12% deletion),\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    (6% deletion) as well as\n                    <jats:italic toggle=\"yes\">FGFR3<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">ERBB3<\/jats:italic>\n                    amplification (each 6%). Gene rearrangements (\n                    <jats:italic toggle=\"yes\">JAZF1-SUZ12<\/jats:italic>\n                    ;\n                    <jats:italic toggle=\"yes\">DNAJB6-PLAG1<\/jats:italic>\n                    ; and\n                    <jats:italic toggle=\"yes\">SFPQ-TFE3<\/jats:italic>\n                    ) were identified in 3 tumors. Integrating histopathologic, immunohistochemical, and genetic findings, tumors from 4 patients were consistent with malignant PEComa (1\n                    <jats:italic toggle=\"yes\">TFE3<\/jats:italic>\n                    -rearranged); 6 were classified as leiomyosarcomas; 3 showed overlapping features of PEComa and other sarcoma types (leiomyosarcoma or low-grade endometrial stromal sarcoma); and 2 were classified as sarcoma, not otherwise specified. Our findings suggest that diagnostically challenging UMTs with myomelanocytic differentiation represent a heterogenous group of neoplasms which harbor a diverse repertoire of somatic genetic alterations; these genetic alterations can aid classification.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001572","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T21:00:21Z","timestamp":1599253221000},"page":"77-92","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":51,"title":["Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation"],"prefix":"10.1097","volume":"45","author":[{"given":"Pier","family":"Selenica","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"GROW School for Oncology and Developmental Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Conlon","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology, Cork University Hospital, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Frosina","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim A.","family":"Jungbluth","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G.H.","family":"Beets-Tan","sequence":"additional","affiliation":[{"name":"GROW School for Oncology and Developmental Biology"},{"name":"Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta K.","family":"Rao","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryma","family":"Benayed","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Solit","sequence":"additional","affiliation":[{"name":"Medicine"},{"name":"Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chiang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hyman","sequence":"additional","affiliation":[{"name":"Medicine"},{"name":"Loxo Oncology Inc., Stamford, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martee L.","family":"Hensley","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajmohan","family":"Murali","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D\u2019Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/his.12594","article-title":"Endometrial stromal sarcoma\u2014the new genetic paradigm","volume":"67","author":"Lee","year":"2015","journal-title":"Histopathology"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/modpathol.2015.140","article-title":"Practical issues related to uterine pathology: endometrial stromal tumors","volume":"29","author":"Nucci","year":"2016","journal-title":"Mod Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"Pan","year":"2008","journal-title":"J Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas","volume":"42","author":"Bennett","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/pbc.24020","article-title":"DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome","volume":"59","author":"Doros","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/modpathol.2011.185","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations","volume":"25","author":"Dehner","year":"2012","journal-title":"Mod Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1073\/pnas.94.15.8047","article-title":"Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma","volume":"94","author":"Davis","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/modpathol.2017.162","article-title":"ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity","volume":"31","author":"Lewis","year":"2018","journal-title":"Mod Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Marin\u00f5-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","article-title":"TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: Morphology, immunophenotype, differential diagnosis","volume":"39","author":"Schoolmeester","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PAS.0000000000000133","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases","volume":"38","author":"Schoolmeester","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","article-title":"Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PAP.0b013e31816613b0","article-title":"Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases","volume":"15","author":"Fadare","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"541626","DOI":"10.1155\/2012\/541626","article-title":"Malignant perivascular epithelioid cell neoplasm: risk stratification and treatment strategies","volume":"2012","author":"Bleeker","year":"2012","journal-title":"Sarcoma"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/his.12145","article-title":"Cutaneous PEComa does not harbour TFE3 gene fusions: Immunohistochemical and molecular study of 17 cases","volume":"63","author":"Llamas-Velasco","year":"2013","journal-title":"Histopathology"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00103","article-title":"Endometrial cancers in BRCA1 or BRCA2 germline mutation carriers: assessment of homologous recombination DNA repair defects","volume":"3","author":"Smith","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djy028","article-title":"The landscape of somatic genetic alterations in breast cancers from atm germline mutation carriers","volume":"110","author":"Weigelt","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","article-title":"Accelerating discovery of functional mutant alleles in cancer","volume":"8","author":"Chang","year":"2018","journal-title":"Cancer Discov"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"e1005850","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2009.05.011","article-title":"Perivascular epithelioid cell neoplasms: pathology and pathogenesis","volume":"41","author":"Folpe","year":"2010","journal-title":"Hum Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/PAS.0b013e318039b218","article-title":"Perivascular epithelioid cell tumors (PEComas) and smooth muscle tumors of the uterus","volume":"31","author":"Fadare","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R36-20250608","article-title":"PNL2: a useful adjunct biomarker to HMB45 in the diagnosis of uterine perivascular epithelioid cell tumor (PEComa)","author":"Valencia-Guerrero","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/2008-132-595-SMTOTU","article-title":"Smooth muscle tumors of the uterus: a practical approach","volume":"132","author":"Toledo","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","article-title":"Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa","volume":"28","author":"Silva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.anndiagpath.2004.10.011","article-title":"A uterine leiomyosarcoma that became positive for HMB45 in the metastasis","volume":"9","author":"Silva","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7800-5-7","article-title":"Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm","volume":"5","author":"Fadare","year":"2008","journal-title":"Int Semin Surg Oncol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200201000-00001","article-title":"Perivascular epithelioid cell tumor (\u2018PEcoma\u2019) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors","volume":"26","author":"Vang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/2002-126-0049-MMIAOT","article-title":"Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study","volume":"126","author":"Makhlouf","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.pas.0000213346.57391.70","article-title":"HMB-45 reactivity in conventional uterine leiomyosarcomas","volume":"31","author":"Simpson","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R44-20250608","first-page":"191A","article-title":"Expression of melanocytic (\u201cPEComa\u201d) markers in smooth muscle tumors of the uterus: an immunohistochemical analysis of 86 cases","volume":"19","author":"Oliva","year":"2006","journal-title":"Mod Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2559.2005.02251.x","article-title":"HMB45+ cells in mixed stromal-smooth muscle tumour of the uterus","volume":"48","author":"Zamecnik","year":"2006","journal-title":"Histopathology"},{"key":"R46-20250608","first-page":"279A","article-title":"Immunohistochemical analysis of HMB-45, MelanA and CathepsinK in a series of 35 uterine leiomyosarcoma","volume":"93","author":"Howitt","year":"2013","journal-title":"Lab Invest"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"e24919","DOI":"10.1371\/journal.pone.0024919","article-title":"Angiomyolipoma have common mutations in TSC2 but no other common genetic events","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"key":"R48-20250608","first-page":"3766","article-title":"Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function","volume":"62","author":"Hunter","year":"2002","journal-title":"Cancer Res"},{"key":"R49-20250608","first-page":"1556","article-title":"Rodent model of reproductive tract leiomyomata: clinical and pathological features","volume":"146","author":"Everitt","year":"1995","journal-title":"Am J Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1349-7006.1995.tb03092.x","article-title":"Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the eker rat model","volume":"86","author":"Kubo","year":"1995","journal-title":"Japanese J Cancer Res"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mc.2940140107","article-title":"Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat","volume":"14","author":"Yeung","year":"1995","journal-title":"Mol Carcinog"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.101132598","article-title":"Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors","volume":"98","author":"Koontz","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1309\/AJCPS88CMJRXZBWA","article-title":"Endometrial stromal sarcomas: Immunoprofile with emphasis on HMB45 reactivity","volume":"141","author":"Albores-Saavedra","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s12253-019-00739-5","article-title":"Leiomyoma with bizarre nuclei: a study of 108 cases focusing on clinicopathological features, morphology, and fumarate hydratase alterations","volume":"26","author":"Gregov\u00e1","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PGP.0000000000000447","article-title":"Fumarate hydratase mutations and alterations in leiomyoma with bizarre nuclei","volume":"37","author":"Zhang","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2019.04.010","article-title":"Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies","volume":"154","author":"Gaillard","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAS.0000000000000324","article-title":"Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome","volume":"39","author":"Liau","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1002\/cncr.31754","article-title":"Loss of ATRX\/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas","volume":"124","author":"Ahvenainen","year":"2018","journal-title":"Cancer"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"R61-20250608","doi-asserted-by":"crossref","first-page":"371.e18","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"R62-20250608","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAS.0000000000001196","article-title":"Novel PLAG1 gene rearrangement distinguishes a subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors","volume":"43","author":"Arias-Stella","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R63-20250608","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41379-019-0299-4","article-title":"Myxoid smooth muscle neoplasia of the uterus: comprehensive analysis by next-generation sequencing and nucleic acid hybridization","volume":"32","author":"Yoon","year":"2019","journal-title":"Mod Pathol"},{"key":"R64-20250608","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13353-018-0463-4","article-title":"Myofibrillar myopathy in the genomic context","volume":"59","author":"Fichna","year":"2018","journal-title":"J Appl Genet"},{"key":"R65-20250608","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fmolb.2016.00063","article-title":"DNAJB6 myopathies: focused review on an emerging and expanding group of myopathies","volume":"3","author":"Ruggieri","year":"2016","journal-title":"Front Mol Biosci"},{"key":"R66-20250608","doi-asserted-by":"crossref","first-page":"53984","DOI":"10.18632\/oncotarget.9803","article-title":"Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"key":"R67-20250608","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"M\u00e4kinen","year":"2017","journal-title":"Mol Cancer"},{"key":"R68-20250608","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer","volume":"107","author":"K\u00e4mpj\u00e4rvi","year":"2012","journal-title":"Br J Cancer"},{"key":"R69-20250608","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod Pathol"},{"key":"R70-20250608","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"key":"R71-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2013.08.005","article-title":"MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors","volume":"45","author":"Schwetye","year":"2014","journal-title":"Hum Pathol"},{"key":"R72-20250608","doi-asserted-by":"crossref","first-page":"e40015","DOI":"10.1371\/journal.pone.0040015","article-title":"MED12 alterations in both human benign and malignant uterine soft tissue tumors","volume":"7","author":"P\u00e9rot","year":"2012","journal-title":"PLoS One"},{"key":"R73-20250608","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ijc.31129","article-title":"Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways","volume":"142","author":"Cuppens","year":"2018","journal-title":"Int J Cancer"},{"key":"R74-20250608","doi-asserted-by":"crossref","first-page":"19447","DOI":"10.3390\/ijms160819447","article-title":"Pyrosequencing-based assays for rapid detection of HER2 and HER3 mutations in clinical samples uncover an E332E mutation affecting HER3 in retroperitoneal leiomyosarcoma","volume":"16","author":"Gonz\u00e1lez-Alonso","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R75-20250608","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1158\/1078-0432.CCR-04-1192","article-title":"Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer","volume":"11","author":"Myers","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R76-20250608","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/cncr.22677","article-title":"Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy","volume":"109","author":"Pantuck","year":"2007","journal-title":"Cancer"},{"key":"R77-20250608","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12672-016-0253-6","article-title":"pAKT expression and response to sorafenib in differentiated thyroid cancer","volume":"7","author":"Yarchoan","year":"2016","journal-title":"Horm Cancer"},{"key":"R78-20250608","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ijc.32579","article-title":"PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma","volume":"146","author":"Roldan-Romero","year":"2020","journal-title":"Int J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:05:42Z","timestamp":1749405942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001572","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}